Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

Cancer Detection and Prevention

Volumn 30, Issue 1, 2006, Pages 34-37

  Battaglia, Tracy A ^a   Ash, Arlene ^a   Prout, Marianne N ^a,b   Freund, Karen M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Breast neoplasms; Chemoprevention; Clinical trials; Decision making; Experimental design; High risk patients; Patient provider relationship; Prevention trials; Primary care providers; Primary prevention; Regional variability; Response rate; Tamoxifen

Indexed keywords

ARTICLE; ASIAN; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CHEMOPROPHYLAXIS; CLINICAL STUDY; COMORBIDITY; GEOGRAPHIC DISTRIBUTION; HUMAN; NEGRO; PHYSICAL MOBILITY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS;

AGED; ATTITUDE OF HEALTH PERSONNEL; CHEMOPREVENTION; CLINICAL TRIALS; COUNSELING; DECISION MAKING; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY;

EID: 33644855767     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.09.005     Document Type: Article

References (22)

1. Chemoprevention of breast cancer: recommendations and rationale. U.S. Preventive Services Task Force Ann Intern Med 137 2002 56 58
2. A.B. Benson, J. Prokop Pregler, J.A. Bean, A.W. Rademaker, B. Eshler, and K. Anderson Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study J Clin Oncol 9 1991 2067 2075
3. R.J. Winn Obstacles to the accrual of patients in clinical trials in the community setting Semin Oncol 21 1994 112 117
4. E.G. Mansour Barriers to clinical trials. Part III: knowledge and attitudes of health care providers Cancer 74 Suppl. 9 1994 2672 2675
5. C. Lerman, B.K. Rimer, M. Daly, E. Lustbader, C. Sands, and A. Balshem Recruiting high risk women into a breast cancer health promotion trial Cancer Epidemiol Biomark Prev 3 3 1994 271 276
6. A.Y. Kinney, C. Richards, S.W. Vernon, and V.G. Vogel The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial Prev Med 27 5 Pt 1 1998 713 719
7. S.M. Frayne, M. Mancuso, M.N. Prout, and K.M. Freund Attitudes of primary care physicians toward cancer-prevention trials: a focus group analysis J Natl Med Assoc 93 11 2001 450 457
8. A.B. Nattinger, M.S. Gottlieb, J. Veum, D. Yahnke, and J.S. Goodwin Geographic variation in the use of breast-conserving treatment for breast cancer New Eng J Med 326 17 1992 1102 1107
9. D.C. Farrow, W.C. Hunt, and J.M. Samet Geographic variation in the treatment of localized breast cancer New Eng J Med 326 17 1992 1097 1101
10. W.G. Cochran, and G.M. Cox Experimental designs 1957 John Wiley & Sons New York, NY
11. B. Fisher, J.P. Costantino, D.L. Wickerham, C.K. Redmond, M. Kavanah, and W.M. Cronin Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 18 1998 1371 1388
12. V.G. Vogel, J.P. Costantino, D.L. Wickerham, W.M. Cronin, and N. Wolmark The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial Clin Breast Cancer 3 2 2002 153 159
13. R. Taylor, and K. Taguchi Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump Ann Fam Med 3 2005 242 247
14. K.W. Yee, J.L. Pater, L. Pho, B. Zee, and L.L. Siu Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 21 8 2003 1618 1623
15. L.F. Hutchins, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and K.S. Albain Underrepresentation of patients 65 years of age or older in cancer-treatment trials New Eng J Med 341 27 1999 2061 2067
16. National Surgical Adjuvant Breast and Bowel Project: P-1 Protocol. Section 6.0 subject eligibility and ineligibility, September 1994.
17. A.B. Nattinger, M.S. Gottlieb, J. Veum, D. Yahnke, and J.S. Goodwin Geographic variation in the use of breast-conserving treatment for breast cancer New Eng J Med 326 17 1992 1102 1107
18. D.C. Farrow, W.C. Hunt, and J.M. Samet Geographic variation in the treatment of localized breast cancer New Eng J Med 326 17 1992 1097 1101
19. E.J. Emanuel, and N.N. Dubler Preserving the physician-patient relationship in the era of managed care JAMA 273 4 1995 323 329
20. R.M. Glass The impact of managed care on patients' trust in medical care and their physicians JAMA 275 21 1996 1693 1697
21. D.S. Asch, M.K. Jedrziewski, and N.A. Christakis Response rate to mail surveys published in medical journals J Clin Epidemiol 50 1997 1129 1136
22. S.L. Marwell, K.M. Fruend, and P.P. Barry Patient factors associated with breast cancer screening among older women J Am Geriatr Soc 44 1996 1210 1214